Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Califano, D."'
Autor:
Francesco Perrone, Ugo De Giorgi, Maria Carmela Piccirillo, Annamaria Ferrero, Andrea Lissoni, Mariateresa Lapresa, Laura Arenare, Giorgio Bogani, Nicoletta Colombo, Daniela Califano, Angiolo Gadducci, Enrico Breda, Raimondo Di Liello, Giovanni Scambia, Andrea De Censi, Gennaro Daniele, Piera Gargiulo, Sandro Pignata, Paolo Scollo, Ciro Gallo, Margherita Nardin, Saverio Cinieri, Rossella Lauria, Francesco Raspagliesi, Vanda Salutari, Simona Frezzini, Carmela Pisano, Stefano Greggi, Domenica Lorusso, G. Artioli, Mariagrazia Distefano, Sabrina Chiara Cecere, Dionyssios Katsaros, Germana Tognon, Clorinda Schettino
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 31(10)
IntroductionThe use of routine antithrombotic prophylaxis is not recommended for advanced cancer patients receiving chemotherapy. The effect of bevacizumab-containing therapy on the risk of thromboembolic events remains controversial in ovarian cance
Autor:
Gustavo Baldassarre, Nicoletta Colombo, Eliana Bignotti, Vincenzo Canzonieri, Vittorio Simeon, Paolo Chiodini, Sabrina Chiara Cecere, Gian Luca Rampioni Vinciguerra, Daniela Califano, Maria Carmela Piccirillo, Francesca Citron, Giovanni Scambia, Daniela Russo, Marco Montella, Francesco Perrone, Gian Franco Zannoni, Anna Spina, Alessandra Ciucci, Germana Tognon, Clorinda Schettino, Laura Arenare, Nunzia Simona Losito, Michele Del Sesto, Rossella De Cecio, Sandro Pignata, Gabriella Ferrandina, Piera Gargiulo, Giosuè Scognamiglio, Daniela Gallo, Simona Signoriello
Publikováno v:
Cancers, Vol 13, Iss 5152, p 5152 (2021)
Cancers
Volume 13
Issue 20
Cancers
Volume 13
Issue 20
Simple Summary The possibility to identify, with appropriate biomarkers, patients that might mostly benefit from any given treatment is the basis of personalized oncology. Cancer biomarkers should be properly identified and validated on a large numbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7daab41216b40ddd8bfc2c29df9471eb
http://hdl.handle.net/10807/198390
http://hdl.handle.net/10807/198390
Autor:
Immacolata Paciolla, C. Pisano, Sergio Venanzio Setola, Sandro Pignata, Nunzia Simona Losito, M. Di Napoli, Sabrina Chiara Cecere, Jole Ventriglia, Daniela Califano, Michele Orditura, Laura Arenare
In patients with recurrent ovarian cancer, the choice of second-line therapy is complex. Several factors have to be considered, such as platinum-free interval (PFI), residual toxicity from the previous treatments, BRCA1/2 gene mutation status. Trebec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17a776f8962f71320ae18e2342e1d014
http://hdl.handle.net/11591/385493
http://hdl.handle.net/11591/385493
Autor:
Daniela Califano, Gerardo Botti, Angelo Ferraro, Gennaro Chiappetta, Massimo Santoro, Alfredo Fusco, Giovanna Maria Pierantoni, Francesca Galdiero, Pierlorenzo Pallante, Mario Monaco, Veronica De Simone, Luciano Pezzullo, Emilia Vuttariello
Publikováno v:
European journal of cancer (1990) 44 (2008): 1015–1021. doi:10.1016/j.ejca.2008.02.039
info:cnr-pdr/source/autori:Chiappetta, Gennaro; Ferraro, Angelo; Vuttariello, Emilia; Monaco, Mario; Galdiero, Francesca; De Simone, Veronica; Califano, Daniela; Pallante, Pierlorenzo; Botti, Gerardo; Pezzullo, Luciano; Pierantoni, Giovanna Maria; Santoro, Massimo; Fusco, Alfredo/titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias/doi:10.1016%2Fj.ejca.2008.02.039/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
European journal of cancer (1990) 44 (2008): 1015–1021.
info:cnr-pdr/source/autori:Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A./titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias./doi:/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
info:cnr-pdr/source/autori:Chiappetta, Gennaro; Ferraro, Angelo; Vuttariello, Emilia; Monaco, Mario; Galdiero, Francesca; De Simone, Veronica; Califano, Daniela; Pallante, Pierlorenzo; Botti, Gerardo; Pezzullo, Luciano; Pierantoni, Giovanna Maria; Santoro, Massimo; Fusco, Alfredo/titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias/doi:10.1016%2Fj.ejca.2008.02.039/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
European journal of cancer (1990) 44 (2008): 1015–1021.
info:cnr-pdr/source/autori:Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A./titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias./doi:/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
We have analysed the expression of the HMGA2 gene in a panel of normal and neoplastic thyroid tissues by immunohistochemistry and quantitative RT-PCR. HMGA2 protein was detectable in four out of 21 follicular carcinomas, 30 out of 45 papillary carcin
Autor:
Daniela Califano, A. Mineo, V de Franciscis, Giancarlo Vecchio, Carmen Monaco, Giovanni Chiappetta, Giovanni Santelli
Publikováno v:
International Journal of Cancer. 63:757-760
We have earlier shown that expression of the human activated Ki-ras, directed by the rat thyroglobulin CTG) promoter in the thyroid gland of transgenic mice, is able to induce thyroid benign tumors, albeit at low incidence. A likely explanation of ou
Autor:
Marianna Colamaio, Daniela Califano, Gennaro Chiappetta, Mimma Bianco, Eleonora Borbone, Pierlorenzo Pallante, Sabrina Battista, Alfredo Fusco, Lucia Russo, Giancarlo Troncone, Antonella Federico
Publikováno v:
The Journal of clinical endocrinology and metabolism 96 (2011): E1915–E1924. doi:10.1210/jc.2011-0408
info:cnr-pdr/source/autori:Colamaio, Marianna; Borbone, Eleonora; Russo, Lucia; Bianco, Mimma; Federico, Antonella; Califano, Daniela; Chiappetta, Gennaro; Pallante, Pierlorenzo; Troncone, Giancarlo; Battista, Sabrina; Fusco, Alfredo/titolo:miR-191 Down-Regulation Plays a Role in Thyroid Follicular Tumors through CDK6 Targeting/doi:10.1210%2Fjc.2011-0408/rivista:The Journal of clinical endocrinology and metabolism/anno:2011/pagina_da:E1915/pagina_a:E1924/intervallo_pagine:E1915–E1924/volume:96
info:cnr-pdr/source/autori:Colamaio, Marianna; Borbone, Eleonora; Russo, Lucia; Bianco, Mimma; Federico, Antonella; Califano, Daniela; Chiappetta, Gennaro; Pallante, Pierlorenzo; Troncone, Giancarlo; Battista, Sabrina; Fusco, Alfredo/titolo:miR-191 Down-Regulation Plays a Role in Thyroid Follicular Tumors through CDK6 Targeting/doi:10.1210%2Fjc.2011-0408/rivista:The Journal of clinical endocrinology and metabolism/anno:2011/pagina_da:E1915/pagina_a:E1924/intervallo_pagine:E1915–E1924/volume:96
CONTEXT: Well-differentiated thyroid carcinomas include papillary (PTC) and follicular (FTC) carcinomas. FTC is usually a more aggressive form of cancer than the more common papillary type. miR-191 expression is frequently altered in several neoplasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf1034df5342420eaaed33c8d257345
Autor:
Lucio Palombini, Daniela Califano, Maria Letizia Motti, Maria Giovanna Russo, Pio Zeppa, Alessia Caleo, Giancarlo Troncone, Ilenia Migliaccio, Antonino Iaccarino, Emiliano A. Palmieri, J C Martinez
Publikováno v:
BMC Clinical Pathology, Vol 5, Iss 1, p 3 (2005)
BMC Clinical Pathology
BMC Clinical Pathology
Background G1/S cell cycle progression requires p27Kip1 (p27) proteolysis, which is triggered by its phosphorylation on threonine (Thr) 187. Since its levels are abundant in quiescent and scarce in cycling cells, p27 is an approved marker for quiesce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e35827166a95d0780c39821161817591
http://hdl.handle.net/11386/3104753
http://hdl.handle.net/11386/3104753
Autor:
Nicole Fabien, Daniela Califano, Angela Celetti, Alfredo Fusco, Christian Paulin, Massimo Santoro, Caterina Battaglia, Maria Luisa Martelli, Carmen Monaco, Giuseppe Viglietto, Domenico Salvatore
Publikováno v:
Scopus-Elsevier
Salvatore D, Celetti A, Fabien N, Paulin C, Martelli ML, Battaglia C, Califano D, Monaco C, Viglietto G, Santoro M, Fusco A. Low frequency of p53 mutations in human thyroid tumors; p53 and Ras mutation in two out of fifty-six thyroid tumours. Eur J E
Autor:
G De Vita, V de Franciscis, Massimo Santoro, Alfredo Fusco, A D'Alessio, Giovanni Santelli, P P Di Fiore, Giancarlo Vecchio, Daniela Califano, Carmen Monaco, G. L. Colucci-D'amato
Germ-line missense mutations of the receptor-like tyrosine kinase ret are the causative genetic event of the multiple endocrine neoplasia (MEN) type 2A and type 2B syndromes and of the familial medullary thyroid carcinoma. We have used the rat pheoch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99fffa6d9d292646c05e6af12253c94d
http://hdl.handle.net/11588/167394
http://hdl.handle.net/11588/167394
Autor:
Vittorio de Franciscis, Carmen Monaco, Daniela Califano, Alfredo Fusco, Giancarlo Vecchio, G. Luca Colucci-D'Amato, Nina A. Dathan, Massimo Santoro, Gabriella De Vita, Giovanni Santelli, Claudia Rizzo, A D'Alessio
Publikováno v:
The Journal of biological chemistry
271 (1996): 29497–29501.
info:cnr-pdr/source/autori:Rizzo C, Califano D, Colucci-D'Amato GL, de Vita G, D'Alessio A, Dathan NA, Fusco A, Monaco C, Santelli G, Vecchio G, Santoro M, de Franciscis V/titolo:Ligand stimulation of a RET chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B/doi:/rivista:The Journal of biological chemistry (Print)/anno:1996/pagina_da:29497/pagina_a:29501/intervallo_pagine:29497–29501/volume:271
271 (1996): 29497–29501.
info:cnr-pdr/source/autori:Rizzo C, Califano D, Colucci-D'Amato GL, de Vita G, D'Alessio A, Dathan NA, Fusco A, Monaco C, Santelli G, Vecchio G, Santoro M, de Franciscis V/titolo:Ligand stimulation of a RET chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B/doi:/rivista:The Journal of biological chemistry (Print)/anno:1996/pagina_da:29497/pagina_a:29501/intervallo_pagine:29497–29501/volume:271
Inherited activating mutations of Ret, a receptor tyrosine kinase, predispose to multiple endocrine neoplasia (MEN) types 2A and 2B and familial medullary thyroid carcinoma. To investigate the effects induced by acute stimulation of Ret, we transfect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e7f9181083e24c9226debb5fdda14a
http://hdl.handle.net/11588/463032
http://hdl.handle.net/11588/463032